Therefore, taking into account the lack of compounds useful to prevent the development of this neurodegenerative disease, blocking VEGF upregulation, through the modulation of the PKCβII/HuR pathway, can constitute a novel pharmacological target that can be exploited in drug discovery in the search of effective molecules against DR. This evidence concerns the gene ELAVL1 and neurodegenerative disease.